Opiates and opioids: What a difference a name makes

Authors

  • Gary M. Reisfield, MD
  • Roger L. Bertholf, PhD
  • George R. Wilson, MD

DOI:

https://doi.org/10.5055/jom.2007.0001

Keywords:

-

Author Biographies

Gary M. Reisfield, MD

Assistant Professor and Director, Division of Palliative Medicine, Department of Community Health & Family Medicine,University of Florida College of Medicine–Jacksonville, Jacksonville, Florida.

Roger L. Bertholf, PhD

Associate Professor and Director, Division of Clinical Chemistry, Toxicology, and Point-of-Care Testing, Department of Pathology, University of Florida College of Medicine–Jacksonville, Jacksonville, Florida.

George R. Wilson, MD

Professor and Chairman, Department of Community Health & Family Medicine, University of Florida College of Medicine–Jacksonville, Jacksonville, Florida.

References

Von Seggern RL, Fitzgerald CP, Adelman LC: Laboratory monitoring of OxyContin (oxycodone): Clinical pitfalls. Headache. 2004; 44: 44-47.

Levy S, Harris SK, Sherritt L, et al.: Drug testing of adolescents in ambulatory medicine. Arch Pediatr Adolesc Med. 2006; 160: 146-150.

Reisfield GM, Bertholf R, Barkin RL, et al.: Urine drug test interpretation: What do physicians know? J Opioid Manag. 2007; 3(2): 80-86.

Downloads

Published

07/01/2007

How to Cite

Reisfield, MD, G. M., R. L. Bertholf, PhD, and G. R. Wilson, MD. “Opiates and Opioids: What a Difference a Name Makes”. Journal of Opioid Management, vol. 3, no. 4, July 2007, pp. 179-80, doi:10.5055/jom.2007.0001.

Issue

Vol. 3 No. 4 (2007): July/August

Section

Editorial

License

Copyright 2005-2024, Weston Medical Publishing, LLC
All Rights Reserved

Crossref
Scopus
Google Scholar
Europe PMC